Ambulanc (Shenzhen) Tech. Co., Ltd was established in 2001 by a group of experts in emergency care. Our brand Amoul® is dedicated to innovation and the development of comprehensive life support solutions, and manufacturing respiratory therapy, cardiopulmonary resuscitation (CPR), anesthesia, emergency care, and critical care devices.
The professional R&D team plays a pivotal role in advancing technologies for pneumatic and turbine life support ventilation, CPR, airway management, conscious sedation devices, and anesthesia machines, serving healthcare professionals and patients globally.
Ambulanc owns 1000+ patents and CFDA medical device registration certificates for Class II and Class III medical equipment, besides a wide range of international certifications such as ISO13485, FDA (EUA), CE, MDL, TAG, etc. Our products are distributed across 100+ countries and regions worldwide.
-
2001SINCE
-
700+EMPLOYEES
-
20000+VALUED CUSTOMERS
-
03Amoul® Showcases Next-Generation Emergency and Critical Care Solutions at ERS Congress 2026 in BarcelonaJoin us at the European Respiratory Society (ERS) Congress 2026, from 5–9 September in Barcelona, Spain. Amoul® is excited to showcase our innovative emergency and critical care solutions at booth no. D2.06. Connect with us to explore how we're transforming patient outcomes in respiratory medicine.news More
English
中文
Pусский
Español
عربى
Français
Português
Deutsch






